Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adult epilepsy.

John S Duncan1, Josemir W Sander1, Sanjay M Sisodiya1

  • 1Department of Clinical and Experimental Epilepsy, Institute of Neurology UCL, Queen Square, London WC1N 3BG, UK and The National Society for Epilepsy, Chalfont St Peter, UK.

Lancet (London, England)
|April 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global Socioeconomic Context and Brain Ageing in Epilepsy: an ENIGMA-Epilepsy study.

medRxiv : the preprint server for health sciences·2026
Same author

Characterizing Onset Limit and Surgical Outcome Factors in Type II Focal Cortical Dysplasia-Related Epilepsy.

Neurology. Clinical practice·2026
Same author

InnerEye-HS: a disease-agnostic clinical tool for hippocampal segmentation.

Brain communications·2026
Same author

Postmortem MRI reveals distinct structural features in sudden unexpected death in epilepsy.

Epilepsia open·2026
Same author

Bilateral ictal eye closure in focal epileptic seizures: SEEG retrospective observational assessment from a tertiary epilepsy center.

Epileptic disorders : international epilepsy journal with videotape·2026
Same author

Dual mechanism of anti-seizure medications in controlling seizure activity.

Brain communications·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

Epilepsy is a common brain disorder with diverse causes and presentations, affecting all ages. Advances in neuroimaging and pharmacogenetics offer hope for personalized treatments and potential cures for refractory epilepsy.

Area of Science:

  • Neurology
  • Genetics
  • Neuroscience

Background:

  • Epilepsies are common, serious brain disorders with varied causes and presentations, affecting all age groups.
  • While childhood epilepsy incidence has decreased, elderly epilepsy rates are rising.
  • Monogenic epilepsies are rare; common epilepsies are complex traits influenced by genetics and environment.

Purpose of the Study:

  • To review the current understanding of epilepsy etiology, diagnosis, and treatment.
  • To highlight advancements in neuroimaging and neurophysiology for epilepsy diagnosis.
  • To explore emerging therapeutic strategies for epilepsy management.

Main Methods:

  • Clinical diagnosis and neurophysiological investigations.
  • Advanced brain imaging techniques for identifying structural and functional causes.

Related Experiment Videos

  • Review of current antiepileptic drug efficacy and pharmacogenetic research.

    • Main Results:

    • Epilepsy diagnosis remains clinical, supported by neurophysiology and advanced brain imaging.
    • Current antiepileptic drugs are effective in 60-70% of patients but do not alter the underlying disease.
    • Pharmacogenetics shows promise for personalized epilepsy treatment.
    • Neurosurgery offers a potential cure for refractory focal epilepsy.

    Conclusions:

    • Epilepsy management is evolving with personalized medicine approaches.
    • Future treatments may include seizure prediction, targeted therapies, and regenerative medicine.
    • Continued research in genetics, imaging, and novel therapeutics is crucial for improving epilepsy outcomes.